Drug Patents owned by Parapro Llc

1. List of Natroba drug patents

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US6063771 PARAPRO LLC Formulations for controlling human lice
Jul, 2023

(a month from now)

US9895388 PARAPRO LLC Methods and compositions useful for controlling cutaneous mites
Nov, 2033

(10 years from now)

Do you want to check out NATROBA patents from before 2022?
Exclusivity Exclusivity Expiration
New Indication (I) Apr 28, 2024

Drugs and Companies using SPINOSAD ingredient

Market Authorisation Date: 18 January, 2011

Treatment: Natroba topical suspension is a pediculicide indicated for the topical treatment of head lice infestation in patients six (6) months of age and older.; The product composition (natroba) is for the top...


More Information on Dosage

900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight

Join them to stay ahead in capturing the next drug going generic

Other things you might be interested in